Literature DB >> 18060716

Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer.

Hyeon-Man Baek1, Hon J Yu, Jeon-Hor Chen, Orhan Nalcioglu, Min-Ying Su.   

Abstract

Proton magnetic resonance spectroscopy ((1)H MRS) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) provide functional information, including vascular volume, vascular permeability and choline (Cho) metabolism. In this study, we applied these two imaging modalities to quantitatively characterize 36 malignant breast lesions in 32 patients and analyzed the correlation between them. Cho concentration was quantified by single-voxel (1)H MRS using water as an internal reference. The measured Cho levels ranged from 0.32 to 10.47 mmol/kg, consistent with previously reported values. In 25 mass-type lesions, the Cho concentration was significantly correlated with tumor size (r=.69, P<.0002). In addition, the Cho level was found to be significantly higher in lesions presenting as mass-type lesions compared to non-mass-type diffuse enhancements (P=.035). The enhancement kinetics from tissues covered within each MRS voxel were measured and analyzed with a two-compartmental model to obtain pharmacokinetic parameters K(trans) and k(ep). A significant correlation was found between the Cho level and the pharmacokinetic parameter k(ep) (r=.62, P<.0001), indicating that tissues with a high Cho level have higher wash-out rates in DCE MRI. The results suggest a correlation between Cho metabolism and angiogenesis activity, which might be explained by the association of Cho with cell replication and angiogenesis required to support tumor growth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18060716      PMCID: PMC2653063          DOI: 10.1016/j.mri.2007.10.002

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  39 in total

1.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?

Authors:  C K Kuhl; P Mielcareck; S Klaschik; C Leutner; E Wardelmann; J Gieseke; H H Schild
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

2.  Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology.

Authors:  Thomas E Yankeelov; William D Rooney; Wei Huang; Jonathan P Dyke; Xin Li; Alina Tudorica; Jing-Huei Lee; Jason A Koutcher; Charles S Springer
Journal:  NMR Biomed       Date:  2005-05       Impact factor: 4.044

3.  Strategies for shimming the breast.

Authors:  Nimrod Maril; Christopher M Collins; Robert L Greenman; Robert E Lenkinski
Journal:  Magn Reson Med       Date:  2005-11       Impact factor: 4.668

Review 4.  Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.

Authors:  P S Tofts
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

5.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

Authors: 
Journal:  J Magn Reson       Date:  1997-11       Impact factor: 2.229

6.  Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy.

Authors:  K A Kvistad; I J Bakken; I S Gribbestad; B Ehrnholm; S Lundgren; H E Fjøsne; O Haraldseth
Journal:  J Magn Reson Imaging       Date:  1999-08       Impact factor: 4.813

7.  Pharmacokinetic parameters analyzed from mr contrast enhancement kinetics of multiple malignant and benign breast lesions detected in the same patients.

Authors:  Min-Y Su; Hon J Yu; Phillip M Carpenter; Christine E McLaren; Orhan Nalcioglu
Journal:  Technol Cancer Res Treat       Date:  2005-06

8.  In vitro proton NMR spectroscopy of extracts from human breast tumours and non-involved breast tissue.

Authors:  I S Gribbestad; H E Fjösne; O A Haugen; G Nilsen; J Krane; S B Petersen; S Kvinnsland
Journal:  Anticancer Res       Date:  1993 Nov-Dec       Impact factor: 2.480

9.  Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results.

Authors:  Anwar R Padhani; Carmel Hayes; Laura Assersohn; Trevor Powles; Andreas Makris; John Suckling; Martin O Leach; Janet E Husband
Journal:  Radiology       Date:  2006-03-16       Impact factor: 11.105

10.  Java-based graphical user interface for the MRUI quantitation package.

Authors:  A Naressi; C Couturier; J M Devos; M Janssen; C Mangeat; R de Beer; D Graveron-Demilly
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.533

View more
  19 in total

1.  Can proton MRS provide useful information for characterizing estrogen receptor status in breast cancer?

Authors:  H-M Baek; J-H Chen; O Nalcioglu; M-Y Su
Journal:  Ann Oncol       Date:  2009-11-30       Impact factor: 32.976

2.  Response monitoring of breast cancer patients receiving neoadjuvant chemotherapy using quantitative ultrasound, texture, and molecular features.

Authors:  Lakshmanan Sannachi; Mehrdad Gangeh; Hadi Tadayyon; Ali Sadeghi-Naini; Sonal Gandhi; Frances C Wright; Elzbieta Slodkowska; Belinda Curpen; William Tran; Gregory J Czarnota
Journal:  PLoS One       Date:  2018-01-03       Impact factor: 3.240

3.  Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS.

Authors:  J-H Chen; R S Mehta; H-M Baek; K Nie; H Liu; M Q Lin; H J Yu; O Nalcioglu; M-Y Su
Journal:  NMR Biomed       Date:  2010-09-22       Impact factor: 4.044

4.  Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer.

Authors:  Michael A Jacobs; Vered Stearns; Antonio C Wolff; Katarzyna Macura; Pedram Argani; Nagi Khouri; Theodore Tsangaris; Peter B Barker; Nancy E Davidson; Zaver M Bhujwalla; David A Bluemke; Ronald Ouwerkerk
Journal:  Acad Radiol       Date:  2010-09-21       Impact factor: 3.173

5.  A feasibility study of quantitative molecular characterization of musculoskeletal lesions by proton MR spectroscopy at 3 T.

Authors:  Laura M Fayad; Xin Wang; Nouha Salibi; Peter B Barker; Michael A Jacobs; Antonio J Machado; Kristy L Weber; David A Bluemke
Journal:  AJR Am J Roentgenol       Date:  2010-07       Impact factor: 3.959

Review 6.  In vivo 1H MRS in the assessment of the therapeutic response of breast cancer patients.

Authors:  Uma Sharma; Hyeon Man Baek; Min Ying Su; Naranamangalam R Jagannathan
Journal:  NMR Biomed       Date:  2011-01-28       Impact factor: 4.044

Review 7.  Breast cancer imaging: a perspective for the next decade.

Authors:  Andrew Karellas; Srinivasan Vedantham
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

Review 8.  In vivo proton magnetic resonance spectroscopy of breast cancer: a review of the literature.

Authors:  Jonathan K P Begley; Thomas W Redpath; Patrick J Bolan; Fiona J Gilbert
Journal:  Breast Cancer Res       Date:  2012-04-19       Impact factor: 6.466

9.  Multiscale kinetic modeling of liposomal Doxorubicin delivery quantifies the role of tumor and drug-specific parameters in local delivery to tumors.

Authors:  B S Hendriks; J G Reynolds; S G Klinz; E Geretti; H Lee; S C Leonard; D F Gaddy; C W Espelin; U B Nielsen; T J Wickham
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2012-11-21

10.  Diagnostic value of breast proton magnetic resonance spectroscopy at 1.5T in different histopathological types.

Authors:  Hyeon-Man Baek
Journal:  ScientificWorldJournal       Date:  2012-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.